The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ibandronic Acid 150 mg film-coated tablets

150 milligram(s) Film-coated tablet

Accord Healthcare Ireland Ltd.PA2315/184/001

Main Information

Trade NameIbandronic Acid 150 mg film-coated tablets
Active SubstancesIbandronate sodium monohydrate
Strength150 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderAccord Healthcare Ireland Ltd.
Licence NumberPA2315/184/001

Group Information

ATC CodeM05BA Bisphosphonates
M05BA06 ibandronic acid

Status

Authorised/WithdrawnAuthorised
Licence Issued21/01/2011
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back